Rigosertib Sodium (ON-01910 sodium salt, with Estybon as trade name) is a synthetic benzyl styryl sulfone in development by Onconova Therapeutics. it has been used in trials studying the treatment and basic science of MDS, RAEB, Cancer, Hepatoma, and Neoplasms, among others. Reference standards of Rigosertib Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Rigosertib Sodium - API Standards [catalogue_number] => PA 18 1180000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 473.47 [form] => C21H24NNaO8S [cas] => 592542-60-4 [pslug] => 592542-60-4-rigosertib-sodium-api-pa181180000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 18 1180000
CAS :
Molecular Formula : C21H24NNaO8S
Molecular Weight : 473.47
stdClass Object ( [pname] => (E/Z)-Rigosertib Sodium Salt [catalogue_number] => PA 18 1181000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 473.47 [form] => C21H24NNaO8S [cas] => 1225497-78-8 [pslug] => 1225497-78-8-e-z-rigosertib-sodium-salt-pa181181000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 18 1181000
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
